E2F1 suppresses Wnt/Β-catenin activity through transactivation of Β-catenin interacting protein ICAT

Oncogene

Volumn 30, Issue 37, 2011, Pages 3979-3984

  Wu, Z ^a   Zheng, S ^a   Li, Z ^a   Tan, J ^a   Yu, Q ^a,b  

^a GENOME INSTITUTE OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

cancer cells; E2F1; ICAT; Wnt b catenin

Indexed keywords

BETA CATENIN; BETA CATENIN INTERACTING PROTEIN 1; BONE MORPHOGENETIC PROTEIN 4; INTERLEUKIN 8; MATRILYSIN; MYC PROTEIN; TCF4 PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR E2F1; UNCLASSIFIED DRUG; WNT PROTEIN;

ARTICLE; DNA BINDING; DOWN REGULATION; HUMAN; HUMAN CELL; OSTEOSARCOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TRANSACTIVATION; TRANSCRIPTION REGULATION;

BETA CATENIN; CELL LINE, TUMOR; E2F1 TRANSCRIPTION FACTOR; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC; TRANSCRIPTIONAL ACTIVATION; WNT PROTEINS;

EID: 80052759334     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2011.129     Document Type: Article

References (23)

1. Bernards R. (2008). Cancer: entangled pathways. Nature 455: 479-480.
2. Bracken AP, Pasini D, Capra M, Prosperini E, Colli E, Helin K et al. (2003). EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer. EMBO J 22: 5323-5335. (Pubitemid 37279943)
3. Bramis J, Zacharatos P, Papaconstantinou I, Kotsinas A, Sigala F, Korkolis DP et al. (2004). E2F-1 transcription factor immunoex-pression is inversely associated with tumor growth in colon adenocarcinomas. Anticancer Res 24: 3041-3047. (Pubitemid 39407184)
4. Cadigan KM. (2008). Wnt-beta-catenin signaling. Curr Biol 18: R943-R947.
5. Clevers H. (2006). Wnt/beta-catenin signaling in development and disease. Cell 127: 469-480.
6. Firestein R, Bass AJ, Kim SY, Dunn IF, Silver SJ, Guney I et al. (2008). CDK8 is a colorectal cancer oncogene that regulates beta-catenin activity. Nature 455: 547-551.
7. Iaquinta PJ, Lees JA. (2007). Life and death decisions by the E2F transcription factors. Curr Opin Cell Biol 19: 649-657. (Pubitemid 350216426)
8. Kim SM, Choi EJ, Song KJ, Kim S, Seo E, Jho EH et al. (2009). Axin localizes to mitotic spindles and centrosomes in mitotic cells. Exp Cell Res 315: 943-954.
9. Klaus A, Birchmeier W. (2008). Wnt signalling and its impact on development and cancer. Nat Rev Cancer 8: 387-398. (Pubitemid 351589714)
10. Logan CY, Nusse R. (2004). The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol 20: 781-810. (Pubitemid 39488658)
11. Moon RT, Kohn AD, De Ferrari GV, Kaykas A. (2004). WNT and beta-catenin signalling: diseases and therapies. Nat Rev Genet 5: 691-701. (Pubitemid 39150127)
12. Morris EJ, Ji JY, Yang F, Di Stefano L, Herr A, Moon NS et al. (2008). E2F1 represses beta-catenin transcription and is antagonized by both pRB and CDK8. Nature 455: 552-556.
13. Nahle Z, Polakoff J, Davuluri RV, McCurrach ME, Jacobson MD, Narita M et al. (2002). Direct coupling of the cell cycle and cell death machinery by E2F. Nat Cell Biol 4: 859-864. (Pubitemid 35331360)
14. Nevins JR. (2001). The Rb/E2F pathway and cancer. Hum Mol Genet 10: 699-703. (Pubitemid 32331578)
15. Polager S, Ginsberg D. (2008). E2F-at the crossroads of life and death. Trends Cell Biol 18: 528-535.
16. Polakis P. (2007). The many ways of Wnt in cancer. Curr Opin Genet Dev 17: 45-51. (Pubitemid 46109296)
17. Sherr CJ, McCormick F. (2002). The RB and p53 pathways in cancer. Cancer Cell 2: 103-112. (Pubitemid 41039110)
18. Tago K, Nakamura T, Nishita M, Hyodo J, Nagai S, Murata Y et al. (2000). Inhibition of Wnt signaling by ICAT, a novel beta-catenin-interacting protein. Genes Dev 14: 1741-1749. (Pubitemid 30602993)
19. Tan J, Zhuang L, Jiang X, Yang KK, Karuturi KM, Yu Q et al. (2006). Apoptosis signal-regulating kinase 1 is a direct target of E2F1 and contributes to histone deacetylase inhibitor-induced apoptosis through positive feedback regulation of E2F1 apoptotic activity. J Biol Chem 281: 10508-10515. (Pubitemid 43864590)
20. Vigo E, Muller H, Prosperini E, Hateboer G, Cartwright P, Moroni MC et al. (1999). CDC25A phosphatase is a target of E2F and is required for efficient E2F-induced S phase. Mol Cell Biol 19: 6379-6395. (Pubitemid 29399342)
21. Wu ZL, Zheng SS, Li ZM, Qiao YY, Aau MY, Yu Q et al. (2010). Polycomb protein EZH2 regulates E2F1-dependent apoptosis through epigenetically modulating Bim expression. Cell Death Differ 17: 801-810.
22. Xie W, Jin L, Mei Y, Wu M. (2009). E2F1 represses beta-catenin/TCF activity by direct up-regulation of Siah1. J Cell Mol Med 13: 1719-1727.
23. Zhao Y, Tan J, Zhuang L, Jiang X, Liu ET, Yu Q et al. (2005). Inhibitors of histone deacetylases target the Rb-E2F1 pathway for apoptosis induction through activation of proapoptotic protein Bim. Proc Natl Acad Sci USA 102: 16090-16095. (Pubitemid 41552872)